Published in Arch Intern Med on January 25, 1993
The fifth report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure (JNC V) Arch Intern Med (1993) 5.08
National High Blood Pressure Education Program Working Group report on primary prevention of hypertension. Arch Intern Med (1993) 1.76
Hemodynamic patterns of age-related changes in blood pressure. The Framingham Heart Study. Circulation (1997) 7.34
Relation of left ventricular mass and geometry to morbidity and mortality in uncomplicated essential hypertension. Ann Intern Med (1991) 6.08
Essential hypertension: renin and aldosterone, heart attack and stroke. N Engl J Med (1972) 4.80
Patterns of left ventricular hypertrophy and geometric remodeling in essential hypertension. J Am Coll Cardiol (1992) 4.65
How common is white coat hypertension? JAMA (1988) 4.42
Low urinary sodium is associated with greater risk of myocardial infarction among treated hypertensive men. Hypertension (1995) 4.35
Association of the renin-sodium profile with the risk of myocardial infarction in patients with hypertension. N Engl J Med (1991) 3.86
Propranolol inhibition of renin secretion. A specific approach to diagnosis and treatment of renin-dependent hypertensive diseases. N Engl J Med (1972) 3.73
Modern strategies to prevent coronary sequelae and stroke in hypertensive patients differ from the JNC V Consensus Guidelines. Am J Hypertens (1994) 2.91
Effect of growth on variability of left ventricular mass: assessment of allometric signals in adults and children and their capacity to predict cardiovascular risk. J Am Coll Cardiol (1995) 2.74
Standardization of M-mode echocardiographic left ventricular anatomic measurements. J Am Coll Cardiol (1984) 2.64
Diagnosis and treatment of primary hyperaldosteronism. Ann Intern Med (1994) 2.62
Renin is not synthesized by cardiac and extrarenal vascular tissues. A review of experimental evidence. Circulation (1994) 2.50
Value of echocardiographic measurement of left ventricular mass in predicting cardiovascular morbid events in hypertensive men. Ann Intern Med (1986) 2.36
Clinical experience with blockade of the renin-angiotensin-aldosterone system by an oral converting-enzyme inhibitor (SQ 14,225, captopril) in hypertensive patients. Prog Cardiovasc Dis (1979) 2.29
Hyperuricemia in primary and renal hypertension. N Engl J Med (1966) 2.22
Renin, angiotensin and aldosterone system in pathogenesis and management of hypertensive vascular disease. Am J Med (1972) 2.10
Calcium-regulating hormones in essential hypertension. Relation to plasma renin activity and sodium metabolism. Ann Intern Med (1986) 2.04
Usefulness and limitations of saralasin, a partial competitive agonist of angioten II, for evaluating the renin and sodium factors in hypertensive patients. Am J Med (1976) 1.98
The renin system: Variations in man measured by radioimmunoassay or bioassay. Kidney Int (1972) 1.87
Atrial natriuretic factor in normal subjects and heart failure patients. Plasma levels and renal, hormonal, and hemodynamic responses to peptide infusion. J Clin Invest (1986) 1.84
Reversal of vascular and renal crises of scleroderma by oral angiotensin-converting-enzyme blockade. N Engl J Med (1979) 1.83
Vasoconstriction-volume analysis for understanding and treating hypertension: the use of renin and aldosterone profiles. Am J Med (1973) 1.82
An angiotensin converting-enzyme inhibitor to identify and treat vasoconstrictor and volume factors in hypertensive patients. N Engl J Med (1974) 1.82
Amiloride. A potassium-sparing natriuretic agent. Circulation (1968) 1.80
Angiotensin-II blockade in man by sar1-ala8-angiotensin II for understanding and treatment of high blood-pressure. Lancet (1973) 1.78
Effects of auriculin (atrial natriuretic factor) on blood pressure, renal function, and the renin-aldosterone system in dogs. Am J Med (1984) 1.76
Prazosin: preliminary report and comparative studies with other antihypertensive agents. Br Med J (1974) 1.76
Atrial natriuretic hormone, the renin-aldosterone axis, and blood pressure-electrolyte homeostasis. N Engl J Med (1985) 1.75
Direct relationship between blood pressure and blood viscosity in normal and hypertensive subjects. Role of fibrinogen and concentration. Am J Med (1981) 1.75
Relation of left ventricular hemodynamic load and contractile performance to left ventricular mass in hypertension. Circulation (1990) 1.72
Blood pressure during normal daily activities, sleep, and exercise. Comparison of values in normal and hypertensive subjects. JAMA (1982) 1.68
Assessment of left ventricular function by the midwall fractional shortening/end-systolic stress relation in human hypertension. J Am Coll Cardiol (1994) 1.67
Treatment of microalbuminuria in hypertensive subjects with elevated cardiovascular risk: results of the IMPROVE trial. Kidney Int (2007) 1.67
Longitudinal study of the renin-angiotensin-aldosterone system in hypertensive pregnant women: deviations related to the development of superimposed preeclampsia. Am J Obstet Gynecol (1990) 1.65
Possible role of renin in hypertension as suggested by renin-sodium profiling and inhibition of converting enzyme. N Engl J Med (1977) 1.64
Relation of obesity and gender to left ventricular hypertrophy in normotensive and hypertensive adults. Hypertension (1994) 1.63
A longitudinal study of urinary creatinine and creatinine clearance in normal subjects. Race, sex, and age differences. Am J Hypertens (1988) 1.60
Purification, sequencing and synthesis of natriuretic and vasoactive rat atrial peptide. Nature (1984) 1.60
Left ventricular hypertrophy in patients with hypertension: importance of blood pressure response to regularly recurring stress. Circulation (1983) 1.60
Possible role of increased blood viscosity in the hemodynamics of systemic hypertension. Am J Cardiol (2000) 1.58
Atrial natriuretic factor: structure and functional properties. Kidney Int (1985) 1.56
The prevalence and correlates of echocardiographic left ventricular hypertrophy among employed patients with uncomplicated hypertension. J Am Coll Cardiol (1986) 1.56
Salt and hypertension. Lancet (1984) 1.52
Low-dose drug combination therapy: an alternative first-line approach to hypertension treatment. Am Heart J (1995) 1.51
Relation between potassium balance and aldosterone secretion in normal subjects and in patients with hypertensive or renal tubular disease. J Clin Invest (1966) 1.51
Impedance cardiography for determination of stroke index. J Appl Physiol (1976) 1.50
Physiologic and clincical observations on furosemide and ethacrynic acid. Ann N Y Acad Sci (1966) 1.50
Oral contraceptives. Renin, aldosterone, and high blood pressure. JAMA (1967) 1.49
Divergent blood pressure responses during short-term sodium restriction in hypertension. Clin Pharmacol Ther (1980) 1.49
Natriuretic activity in plasma and urine of salt-loaded man and sheep. J Clin Invest (1969) 1.48
Hypertension and a tumor of the glomus jugulare region. Evidence for epinephrine biosynthesis. Am J Hypertens (1993) 1.47
Disparate patterns of aldosterone response during diuretic treatment of hypertension. Ann Intern Med (1977) 1.45
Cardiac arrest postoperatively in a patient infected with ascaris, the roundworm. Chest (1989) 1.43
Role of the kidney in congestive heart failure. Relationship of cardiac index to kidney function. Drugs (1990) 1.43
Echocardiographic assessment of cardiac anatomy and function in hypertensive subjects. Circulation (1979) 1.42
What is the role of ambulatory blood pressure monitoring in the management of hypertensive patients? Hypertension (1985) 1.42
The influence of potassium administration and of potassium deprivation on plasma renin in normal and hypertensive subjects. J Clin Invest (1970) 1.42
Prevalence of carpal tunnel syndrome and wrist osteoarthritis in long-term paraplegic patients compared with controls. J Hand Surg Eur Vol (2013) 1.41
Plasma renin activity: a risk factor for myocardial infarction in hypertensive patients. Am J Hypertens (1997) 1.41
Recurrent pulmonary oedema in hypertension due to bilateral renal artery stenosis: treatment by angioplasty or surgical revascularisation. Lancet (1988) 1.40
Measuring hypertensive cardiovascular risk: the vascular overload concept. Am Heart J (1994) 1.40
Renin and prorenin: advances and declines in methodology. Clin Chem (1996) 1.40
The use of short-term ambulatory blood pressure monitoring in differing forms of hypertension. Clin Exp Hypertens A (1983) 1.40
Left ventricular hypertrophy and antihypertensive therapy. Am Fam Physician (1992) 1.40
Furosemide. A clinical evaluation of its diuretic action. Circulation (1966) 1.40
Interruption of the renin-angiotensin system in hypertensive patients by captopril induces sustained reduction in aldosterone secretion, potassium retention and natruiresis. Hypertension (1980) 1.39
Relation of blood viscosity to demographic and physiologic variables and to cardiovascular risk factors in apparently normal adults. Circulation (1990) 1.39
CORRELATION OF STRUCTURE AND FUNCTION IN THE HANDLING OF GLUCOSE BY THE NEPHRONS OF THE CANINE KIDNEY. J Clin Invest (1961) 1.37
Midwall left ventricular mechanics. An independent predictor of cardiovascular risk in arterial hypertension. Circulation (1996) 1.37
Prorenin and other large molecular weight forms of renin. Endocr Rev (1980) 1.33
THE NATURE OF THE ACTION OF INTRAVENOUS ALDOSTERONE: EVIDENCE FOR A ROLE OF THE HORMONE IN URINARY DILUTION. J Clin Invest (1961) 1.33
Estimating renin participation in hypertension: superiority of converting enzyme inhibitor over saralasin. Am J Med (1976) 1.33
Percutaneous transluminal renal angioplasty in renovascular hypertension due to atheroma or fibromuscular dysplasia. N Engl J Med (1983) 1.30
Suppression of the renin-angiotensin system by intravenous digoxin in chronic congestive heart failure. Am J Med (1983) 1.27
Malignant hypertension resulting from deoxycorticosterone acetate and salt excess: role of renin and sodium in vascular changes. Circ Res (1975) 1.27
Implications of a health lifestyle and medication analysis for improving hypertension control. Arch Intern Med (2000) 1.26
Beta-blockers and plasma renin activity in hypertension. Br Med J (1974) 1.25
Elevated blood viscosity in patients with borderline essential hypertension. Hypertension (1983) 1.24
Human urinary kallikrein converts inactive to active renin and is a possible physiological activator of renin. Nature (1978) 1.23
Secondary aldosteronism and reduced plasma renin in hypertensive disease. Trans Assoc Am Physicians (1967) 1.22
The reproducibility of average ambulatory, home, and clinic pressures. Hypertension (1988) 1.21
Angiotensin II vascular receptors: their avidity in relationship to sodium balance, the autonomic nervous system, and hypertension. J Clin Invest (1972) 1.21
Prorenin in high concentrations in human ovarian follicular fluid. Science (1986) 1.20
Effect of corticotropin on aldosterone excretion and plasma renin in normal subjects, in essential hypertension and in primary aldosteronism. J Clin Endocrinol Metab (1968) 1.20
Common femoral artery ligation and local debridement: a safe treatment for infected femoral artery pseudoaneurysms. J Vasc Surg (2001) 1.20
What is the value of home blood pressure measurement in patients with mild hypertension? Hypertension (1984) 1.19
Monotherapy with labetalol compared with propranolol. Differential effects by race. J Clin Hypertens (1985) 1.18
Regulation of glomerular filtration rate in chronic congestive heart failure patients. Kidney Int (1988) 1.18
Hypertension of renal origin: evidence for two different mechanisms. Science (1971) 1.16
Prior receptor occupancy as a determinant of the pressor activity of infused angiotensin II in the rat. Circ Res (1975) 1.16
Nephrotic syndrome: vasoconstriction and hypervolemic types indicated by renin-sodium profiling. Ann Intern Med (1979) 1.15
Potassium balance and the control of renin secretion. J Clin Invest (1970) 1.15
Variable response to oral angiotensin-converting-enzyme blockade in hypertensive scleroderma patients. Arthritis Rheum (1982) 1.14
Physiological and pathological variations of plasma angiotensin II in man. Correlation with renin activity and sodium balance. Circ Res (1969) 1.14